Загрузка...
Emerging role of multikinase inhibitors for refractory thyroid cancer
Thyroid cancer incidence continues to increase, remaining the most common endocrine malignancy. The need for effective systemic therapies combined with high incidence of driver mutations and overexpression of molecular pathways make refractory thyroid cancer an ideal candidate for treatment with nov...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3421474/ https://ncbi.nlm.nih.gov/pubmed/22904617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S24465 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|